Multiplikator forward rega marang pendapatan Fortress Biotech Corp (FBIO)

Logo perusahaan publik Fortress Biotech, Inc. (FBIO)

The forward P/S history of Fortress Biotech, Inc. (FBIO), which leverages M&A strategic expertise and subsidiary startups, demonstrates a trend where the parameter reaches 1.00. The current trajectory is based on the success of portfolio companies in bringing drugs to market, although the holding company's financial stability remains under pressure from debt obligations and regulatory risks regarding the approval of new medications.

FBIO Fortress Biotech: Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ing interval 04.07.2022 - 13.11.2026

Ringkesan rincian data analitis Fortress Biotech Corp (FBIO)

- rega pasar lan target rega analis:
Bagan rega Fortress Biotech|FBIO - Target median analis
- rincian kapitalisasi pasar:
Biji pasar Fortress Biotech Corp|FBIO - Nilai Dipunlarasaken Utang lan Kas
- rincian valuasi buku bisnis:
Aset Bersih saben Siji Saham Fortress Biotech|FBIO - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku fortressbiotech.com|FBIO - Total Aset Bisnis
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Fortress Biotech, Inc.|FBIO - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Fortress Biotech, Inc.|FBIO - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Fortress Biotech Corp|FBIO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Fortress Biotech|Rasio cepet fortressbiotech.com
- data bathi bisnis lan rasio investasi:
FBIO - Bathi resik taunan|Bathi mangsa ngarep Fortress Biotech, Inc.|FBIO - Kapitalisasi marang bathi|Pangali Forward P/E Fortress|FBIO - Rasio kapitalisasi marang bathi lan wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Fortress Biotech Corp|FBIO - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Fortress Biotech|FBIO - Bathi saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan fortressbiotech.com|FBIO - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Fortress Biotech, Inc.
- rincian pendapatan lan dodolan:
FBIO - Pendapatan dodolan perusahaan|Prakiraan volume dodolan Fortress Biotech|FBIO - Rega marang dodolan|Rasio rega marang prakiraan pendapatan Fortress Biotech Corp
Analisis wiwitan perusahaan:FBIO (Fortress Biotech)
Sampel barang Fortress Biotech, Inc.

Efficient digital capital routing into the logistics of innovative drugs at Fortress Biotech, Inc. (FBIO) directly impacts the pace of revenue scaling. The forward P/S metric reflects the market premium for this potential, determining the balance between overvaluation and undervaluation of the business through an analysis of sustainable price corridors, where deviations from the norm signal a fundamental shift in the prospects for capturing new market niches.

Karo sapa Fortress Biotech, Inc. saingan

Rasio rega marang prakiraan pendapatan NovoCure NVCR|Rasio kapitalisasi marang dodolan sing dikarepake Alpha Tau Medical Ltd (DRTS)|ACRV: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan ALLR (Allarity Therapeutics)